Ms. Pavone built Inlightened into a technology-enabled platform with a curated network reaching 900,000-plus healthcare professionals across 100-plus specialties. She also established partnerships with more than 20 leading global life sciences organizations. In 2025, Ms. Pavone led her team to achieve $1 million in gross profit and more than 120% year-over-year growth, increasing the number of experts in Inlightened’s network by 72% over 2024 and enabling clients to access hard-to-reach expertise from payers, advanced practice providers, oncologists and bio-coordinators. The company was acquired by Locum Tenens in August 2023. Ms. Pavone continues as Co-Founder and president following the company’s acquisition. Ms. Pavone is a recognized thought leader featured in PharmExec, Kevin MD and Transformation in Trials, and published an essay in the Boston Business Journal‘s “In Her Own Words” column.
